Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vahtera

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Blood|July 15, 1994
Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levelsH Mikkola, M Syrjälä, V Rasi, et al.
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusingG Leone, V De Stefano, R Ferrelli, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operationsJ Petăjă, K Peltola, H Sairanen, et al.
Metabolism: Clinical and Experimental|June 1, 1997
Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose toleranceL Niskanen, U S Schwab, E S Sarkkinen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2013
Von Willebrand disease in FinlandR Kekomäki, V Rasi, F Ebeling, et al.
European Heart Journal|October 1, 1994
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis StudyV Salomaa, V Rasi, J Pekkanen, et al.
Thrombosis and Haemostasis|June 3, 1998
Intra- and interindividual variability of hemostatic factors and traditional cardiovascular risk factors in a three-year follow-upV Salomaa, V Rasi, J Stengård, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective studyJ H Stengård, V Salomaa, V Rasi, et al.
Thrombosis Research|May 15, 1995
Fibrinogenemia Tampere--a dysfibrinogenemia with defective gelation and thromboembolic diseaseB Hessel, A M Silveira, K Carlsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patientsT Jouhikainen, H Julkunen, O Vaarala, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Blood|July 15, 1994
Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levelsH Mikkola, M Syrjälä, V Rasi, et al.
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusingG Leone, V De Stefano, R Ferrelli, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operationsJ Petăjă, K Peltola, H Sairanen, et al.
Metabolism: Clinical and Experimental|June 1, 1997
Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose toleranceL Niskanen, U S Schwab, E S Sarkkinen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2013
Von Willebrand disease in FinlandR Kekomäki, V Rasi, F Ebeling, et al.
European Heart Journal|October 1, 1994
Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis StudyV Salomaa, V Rasi, J Pekkanen, et al.
Thrombosis and Haemostasis|June 3, 1998
Intra- and interindividual variability of hemostatic factors and traditional cardiovascular risk factors in a three-year follow-upV Salomaa, V Rasi, J Stengård, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective studyJ H Stengård, V Salomaa, V Rasi, et al.
Thrombosis Research|May 15, 1995
Fibrinogenemia Tampere--a dysfibrinogenemia with defective gelation and thromboembolic diseaseB Hessel, A M Silveira, K Carlsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patientsT Jouhikainen, H Julkunen, O Vaarala, et al.
Pageof 5